secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001493152-23-005752
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech Q4 revenue jumps 119% YoY to $15.3M; full-year revenue up 90% to $45.8M
--------------------------------------------------------------------------------

- Net revenue $15.3M in Q4 2022 (up 119% from $7.0M); full-year $45.8M (up 90% from $24.1M).
- Operating loss expected $2.0M-$3.5M in Q4 vs $3.4M loss prior year; full-year loss $11.0M-$12.5M vs $7.4M.
- Cash and equivalents $9.0M as of December 31, 2022.
- Recorded non-cash loss on dissolution of Sanara Pulsar of $1.0M in Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315223005752/0001493152-23-005752-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315223005752/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005752

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer